Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients

Cellular Oncology

Volumn 31, Issue 4, 2009, Pages 317-328

  Graveland, A Peggy ^a   De Maaker, Michiel ^a   Braakhuis, Boudewijn J M ^a   De Bree, Remco ^a   Eerenstein, Simone E J ^a   Bloemena, Elisabeth ^a,b   Leemans, C René ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Head and neck cancer; HLy 6D; Minimal residual cancer; Molecular diagnosis; QRT PCR; Surgical margin

Indexed keywords

MOLECULAR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIGENS, LY; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; TUMOR MARKERS, BIOLOGICAL;

EID: 68149156774     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0474     Document Type: Article

References (30)

1. C.R. Leemans, R. Tiwari, J.J. Nauta, I. van der Waal and G.B. Snow, Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prog-nostic factor, Cancer 73 (1994), 187-190.
2. V.M.M. van Houten, M.P. Tabor, M.W.M. van den Brekel, J.A. Kummer, F. Denkers, J. Dijkstra, C.R. Leemans, I. van der Waal, G.B. Snow and R.H. Brakenhoff, Mutated p53 as a molecular marker for the diagnosis of head and neck cancer, J. Pathol. 198 (2002), 476-486.
3. B.J.M. Braakhuis, M.P. Tabor, J.A. Kummer, C.R. Leemans and R.H. Brakenhoff, A genetic explanation of Slaughter's con-cept of field cancerization: evidence and clinical implications, Cancer Res. 63 (2003), 1727-1730.
4. M.P. Tabor, R.H. Brakenhoff, H.J. Ruijter-Schippers, J.A. Kummer, C.R. Leemans and B.J.M. Braakhuis, Genetically al-tered fields as origin of locally recurrent head and neck cancer: a retrospective study, Clin. Cancer Res. 10 (2004), 3607-3613.
5. H. Lumerman, P. Freedman and S. Kerpel, Oral epithelial dys-plasia and the development of invasive squamous cell carci-noma, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 79 (1995), 321-329.
6. S. Jr. Silverman, M. Gorsky and G.E. Kaugars, Leukoplakia, dysplasia, and malignant transformation, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 82 (1996), 117.
7. M. Weijers, G.B. Snow, D.P. Bezemer, J.E. van der Wal and I. van der Waal, The status of the deep surgical margins in tongue and floor of mouth squamous cell carcinoma and risk of local recurrence; an analysis of 68 patients, Int. J. Oral Max-illofac. Surg. 33 (2004), 146-149.
8. M. Weijers, G.B. Snow, P.D. Bezemer, J.E. van der Wal and I. van der Waal, The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients, J. Oral Pathol. Med. 31 (2002), 11-15.
9. K. Bjordal, S. Kaasa and A. Mastekaasa, Quality of life in pa-tients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy, Int. J. Radiat. Oncol. Biol. Phys. 28 (1994), 847-856.
10. V.M.M. van Houten, C.R. Leemans, J.A. Kummer, J. Dijkstra, D.J. Kuik, M.W.M. van den Brekel, G.B. Snow and R.H. Brak-enhoff, Molecular diagnosis of surgical margins and local re-currence in head and neck cancer patients: a prospective study, Clin. Cancer Res. 10 (2004), 3614-3620.
11. J.A. Brennan, L. Mao, R.H. Hruban, J.O. Boyle, Y.J. Eby, W.M. Koch, S.N. Goodman and D. Sidransky, Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck, N. Engl. J. Med. 332 (1995), 429-435.
12. E.J.C Nieuwenhuis, I. van der Waal, C.R. Leemans, J.A. Kum-mer, R. Pijpers, J.A. Castelijns, R.H, Brakenhoff and G.B. Snow, Histopathologic validation of the sentinel node con-cept in oral and oropharyngeal squamous cell, carcinoma, Head Neck 27 (2005), 150-158.
13. E.J.C. Nieuwenhuis, L.H. Jaspars, J.A. Castelijns, B. Bakker, R.G. Wishaupt, F. Denkers, C.R. Leemans, G.B. Snow and R.H. Brakenhoff, Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates, Clin. Cancer Res. 9 (2003), 755-761.
14. V.M.M. van Houten, M.P. Tabor, M.W.M. van den Brekel, F. Denkers, R.G. Wishaupt, J.A. Kummer, G.B. Snow and R.H. Brakenhoff, Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions, Clin. Cancer Res. 6 (2000), 3803-3816.
15. A. Zippelius and K. Pantel, RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview, Ann. NY Acad. Sci. 906 (2000), 110-123.
16. J.J. Quak, A.J.M. Balm, G.A.M.S. van Dongen, J.G. Brakkee, R.J. Scheper, G.B. Snow and C.J. Meijer, A 22-kd surface anti-gen detected by monoclonal antibody E 48 is exclusively ex-pressed in stratified squamous and transitional epithelia, Am. J. Pathol. 136 (1990), 191-197.
17. A.G. de Nooij-van Dalen, G.A.M.S. van Dongen, S.J. Smeets, E.J.C. Nieuwenhuis, M. Stigter-van Walsum, G.B. Snow and R.H. Brakenhoff, Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma, Int. J. Cancer 103 (2003), 768-774.
18. R.H. Brakenhoff, J.G. Stroomer, C. ten Brink, R. de Bree, S.M. Weima, G.B. Snow and G.A.M.S. van Dongen, Sensitive detec-tion of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction, Clin. Cancer Res. 5 (1999), 725-732.
19. E.J.C. Nieuwenhuis, C.R. Leemans, J.A. Kummer, F. Denkers, G.B. Snow and R.H. Brakenhoff, Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction, Lab Invest 83 (2003), 1233-1240.
20. D.R. Colnot, E.J.C. Nieuwenhuis, D.J. Kuik, C.R. Leemans, J. Dijkstra, G.B. Snow, G.A.M.S. van Dongen and R.H. Brak-enhoff, Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reac-tion in bone marrow of head and neck cancer patients, Clin. Cancer Res. 10 (2004), 7827-7833.
21. K. Shanmugaratnam and L.H. Sobin, The World Health Orga-nization histological classification of tumours of the upper res-piratory tract and ear. A commentary on the second edition, Cancer 71 (1993), 2689-2697.
22. J.G. Batsakis, Surgical excision margins: a pathologist's per-spective, Adv. Anat. Pathol. 6 (1999), 140-148.
23. S. Loseke, E. Grage-Griebenow, A. Wagner, K. Gehlhar and A. Bufe, Differential expression of IFN-alpha subtypes in hu-man PBMC: evaluation of novel real-time PCR assays, J. Im-munol. Methods 276 (2003), 207-222.
24. T.R. Loree and E.W. Strong, Significance of positive margins in oral cavity squamous carcinoma, Am. J. Surg. 160 (1990), 410-414.
25. D.N. Sutton, J.S. Brown, S.N. Rogers, E.D. Vaughan and J.A. Woolgar, The prognostic implications of the surgical margin in oral squamous cell carcinoma, Int. J. Oral Maxillofac. Surg. 32 (2003), 30-34.
26. L.A. Ravasz, P.J. Slootweg, G.J. Hordijk, R Smit and I. van der Tweel, The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma, J. Craniomaxillo-fac. Surg. 19 (1991), 314-318.
27. L. Tao, M. Lefèvre, S. Ricci, P. Saintigny, P. Callard, S. Perie, R. Lacave, J.F. Bernaudin and S.G. Lacau, Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA, Br. J. Cancer 94 (2006), 1164-1169.
28. L. Xi, D.G. Nicastri, T. El-Hefnawy, S.J. Hughes, J.D. Luketich and T.E. Godfrey, Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers, Clin. Chem. 53 (2007), 1206-1215.
29. R.L. Ferris, L. Xi, S. Raja, J.L. Hunt, J. Wang, W.E. Gooding, L. Kelly, J. Ching, J.D. Luketich and T.E. Godfrey, Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head, and neck, Cancer Res. 65 (2005), 2147-2156.
30. N.L. Van Hal, G.A.M.S. van Dongen, M. Stigter-van Walsum, G.B. Snow and R.H. Brakenhoff, Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma, Int. J. Cancer 82 (1999), 837-845.